Versant Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130K | Sell |
588
-314
| -35% | -$86.9K | 0.01% | 800 |
|
|
2026
Q1 | $266K | Buy |
902
+390
| +76% | +$116K | 0.03% | 487 |
|
|
2025
Q4 | $140K | Buy |
512
+21
| +4% | +$5.71K | 0.02% | 622 |
|
|
2025
Q3 | $133K | Buy |
491
+24
| +5% | +$6.53K | 0.02% | 616 |
|
|
2025
Q2 | $129K | Buy |
467
+54
| +13% | +$14.7K | 0.02% | 583 |
|
|
2025
Q1 | $110K | Buy |
413
+186
| +82% | +$45.9K | 0.02% | 600 |
|
|
2024
Q4 | $52.7K | Buy |
227
+73
| +47% | +$16.8K | 0.01% | 564 |
|
|
2024
Q3 | $34K | Buy |
154
+18
| +13% | +$3.73K | 0.01% | 587 |
|
|
2024
Q2 | $26.7K | Buy |
136
+73
| +116% | +$15.1K | 0.01% | 602 |
|
|
2024
Q1 | $13.6K | Sell |
63
-4
| -6% | -$840 | ﹤0.01% | 638 |
|
|
2023
Q4 | $14.1K | Buy |
67
+1
| +2% | +$213 | ﹤0.01% | 613 |
|
|
2023
Q3 | $13.2K | Buy |
66
+2
| +3% | +$398 | ﹤0.01% | 624 |
|
|
2023
Q2 | $11.9K | Sell |
64
-5
| -7% | -$924 | ﹤0.01% | 711 |
|
|
2023
Q1 | $13.2K | Sell |
69
-9
| -12% | -$1.63K | ﹤0.01% | 633 |
|
|
2022
Q4 | $13.1K | Hold |
78
| – | – | ﹤0.01% | 597 |
|
|
2022
Q3 | $14K | Hold |
78
| – | – | 0.01% | 530 |
|
|
2022
Q2 | $16K | Sell |
78
-39
| -33% | -$8.27K | 0.01% | 494 |
|
|
2022
Q1 | $28K | Sell |
117
-5
| -4% | -$1.17K | 0.01% | 380 |
|
|
2021
Q4 | $28K | Hold |
122
| – | – | 0.01% | 382 |
|
|
2021
Q3 | $24K | Buy |
122
+21
| +21% | +$4.25K | 0.01% | 405 |
|
|
2021
Q2 | $21K | Sell |
101
-137
| -58% | -$28.9K | 0.01% | 458 |
|
|
2021
Q1 | $49K | Buy |
238
+11
| +5% | +$2.17K | 0.02% | 280 |
|
|
2020
Q4 | $41K | Buy |
227
+7
| +3% | +$1.19K | 0.02% | 297 |
|
|
2020
Q3 | $36K | Sell |
220
-4
| -2% | -$674 | 0.02% | 275 |
|
|
2020
Q2 | $36K | Buy |
224
+4
| +2% | +$717 | 0.02% | 259 |
|
|
2020
Q1 | $38K | Buy |
220
+110
| +100% | +$21.9K | 0.02% | 224 |
|
|
2019
Q4 | $22K | Sell |
110
-19
| -15% | -$3.9K | 0.01% | 429 |
|
|
2019
Q3 | $27K | Buy |
129
+11
| +9% | +$2.3K | 0.01% | 358 |
|
|
2019
Q2 | $22K | Sell |
118
-75
| -39% | -$13.8K | 0.01% | 436 |
|
|
2019
Q1 | $31K | Hold |
193
| – | – | 0.01% | 418 |
|
|
2018
Q4 | $36K | Hold |
193
| – | – | 0.02% | 327 |
|
|
2018
Q3 | $32K | Sell |
193
-22
| -10% | -$3.7K | 0.01% | 434 |
|
|
2018
Q2 | $35K | Hold |
215
| – | – | 0.01% | 405 |
|
|
2018
Q1 | $34K | Sell |
215
-3
| -1% | -$478 | 0.01% | 415 |
|
|
2017
Q4 | $31K | Hold |
218
| – | – | 0.01% | 454 |
|
|
2017
Q3 | $29K | Sell |
218
-9
| -4% | -$1.14K | 0.02% | 429 |
|
|
2017
Q2 | $28K | Sell |
227
-5
| -2% | -$598 | 0.02% | 438 |
|
|
2017
Q1 | $27K | Hold |
232
| – | – | 0.01% | 470 |
|
|
2016
Q4 | $26K | Sell |
232
-1
| -0.4% | -$111 | 0.01% | 504 |
|
|
2016
Q3 | $24K | Buy |
233
+13
| +6% | +$1.36K | 0.01% | 502 |
|
|
2016
Q2 | $21K | Buy |
220
+13
| +6% | +$1.23K | 0.01% | 518 |
|
|
2016
Q1 | $19K | Buy |
207
+16
| +8% | +$1.46K | 0.01% | 531 |
|
|
2015
Q4 | $17K | Buy |
+191
| New | +$18K | 0.01% | 548 |
|
Other funds holding CME
PAM
SP
HCM
CF
OIAM
SI
AAMU
Versant Capital Management's CME Position: Q2 2026 in Review
Versant Capital Management reduced its CME Group (CME) stake by 35% in Q2 2026, selling an estimated $86.9K and leaving 588 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #800.
Versant Capital Management first reported a position in CME in Q4 2015 and has held it in 43 quarters since. The position peaked at $266K in Q1 2026. 309 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Versant Capital Management held 588 shares of CME Group worth $130K as of Q2 2026.
- Versant Capital Management sold 314 CME Group shares in Q2 2026, an estimated $86.9K.
- CME Group made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #800 holding.
- Versant Capital Management first reported a position in CME Group in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's CME Group position peaked at $266K in Q1 2026.
- 309 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.